Related Experiment Video
Updated: Jul 5, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
Published on: April 2, 2021
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal
T M Hohl1, M Feldmesser, D S Perlin
1Infectious Diseases Service, Memorial Sloan-Kettering Cancer Center and Immunology Program, Sloan-Kettering Institute, New York 10021, USA. hohlt@mskcc.org
Abstract:
Echinocandins target fungal beta-1,3 glucan synthesis and are used clinically to treat invasive aspergillosis. Although echinocandins do not completely inhibit in vitro growth of Aspergillus fumigatus, they do induce morphological changes in fungal hyphae. Because beta-1,3 glucans activate host antifungal pathways via the Dectin-1 receptor, we investigated the effect of echinocandins on inflammatory responses to A. fumigatus. Caspofungin- or micafungin-treated conidia and germlings induced less secretion of tumor necrosis factor (TNF) and CXCL2 by macrophages than did their untreated counterparts. Diminished secretion of TNF and CXCL2 correlated with diminished beta-glucan exposure on echinocandin-treated germ tubes. In contrast to treated conidia and germlings, echinocandin-treated hyphae stimulated increased release of TNF and CXCL2 by macrophages and demonstrated intense staining with a beta-glucan-specific antibody, particularly at hyphal tips. Our experiments demonstrate that echinocandin-induced morphological changes in A. fumigatus hyphae are accompanied by increased beta-glucan exposure, with consequent increases in Dectin-1-mediated inflammatory responses by macrophages.
Insights
Echinocandins alter Aspergillus fumigatus morphology, increasing fungal beta-glucan exposure. This enhances Dectin-1-mediated inflammatory responses, impacting treatment strategies for invasive aspergillosis.
Area of Science:
- Mycology
- Immunology
- Pharmacology
Background:
- Echinocandins are antifungal drugs targeting beta-1,3 glucan synthesis.
- They are used to treat invasive aspergillosis but do not fully inhibit Aspergillus fumigatus growth.
- Beta-1,3 glucans are key fungal components that activate host immune responses via Dectin-1.
Purpose of the Study:
- To investigate the impact of echinocandins on inflammatory responses to Aspergillus fumigatus.
- To determine if echinocandin-induced morphological changes affect beta-glucan exposure and host immune cell activation.
Main Methods:
- Treatment of Aspergillus fumigatus conidia and germlings with echinocandins (caspofungin, micafungin).
- Co-incubation of treated and untreated fungal forms with macrophages.
- Measurement of inflammatory cytokine secretion (TNF, CXCL2).
- Assessment of beta-glucan exposure using antibody staining.
Main Results:
- Echinocandin-treated conidia and germlings showed reduced TNF and CXCL2 secretion by macrophages, correlating with decreased beta-glucan exposure.
- Echinocandin-treated hyphae induced increased TNF and CXCL2 release from macrophages.
- Hyphal tips of echinocandin-treated fungi exhibited intense beta-glucan staining.
Conclusions:
- Echinocandin treatment induces morphological changes in Aspergillus fumigatus hyphae, leading to increased beta-glucan exposure.
- This increased exposure enhances Dectin-1-mediated inflammatory responses by macrophages.
- Findings suggest a complex interplay between echinocandins, fungal morphology, and host immunity in aspergillosis treatment.
Related Concept Videos
Antifungal Agents
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Fungal Phylum Microsporidia
Candidiasis

